Search for Clinical Trials

This study is a first in human Phase 1 study that involves patients with a type of cancer called HER2 (Human Epidermal Growth Factor Receptor 2)…
  • Cancer - Breast
  • Cancer - Head/Neck
  • Cancer - Gastric/Stomach
  • Cancer - Esophagus
  • Cancer - Colon/Rectal
  • Cancer - Bladder
  • Cancer - All
  • Cancer - Pancreas
  • Cancer - Lung
A study to determine the change from baseline to post-treatment Ki67 in some breast cancer tissue.
  • Cancer - Breast
This study is being done to evaluate the safety and effectiveness of three different drug combinations for patients with HER2-positive metastatic…
  • Cancer - Breast
  • Cancer - Metastatic
The main purpose of this study is to look at the safety and effectiveness of the standard anti-HER2-targeted therapies.
  • Cancer - Breast
This study is being done to learn more about the safety and effectiveness of an investigational oral medication called ORIN1001 for people with…
  • Cancer - Breast
  • Cancer - Metastatic
A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
  • Cancer - Breast
  • Cancer - Metastatic
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
  • Cancer - Breast
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone. Tucatinib is a type of drug…
  • Cancer - Breast
  • Cancer - Metastatic
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
  • Cancer - Breast
A study to determine if the addition of atezolizumab to chemotherapy improves response in the breast and lymph nodes in patients with triple-negative…
  • Cancer - Breast
Back to topback-to-top